Delivery Order SPE2DB22D2007-SPE2DB25FH6LJ

Award Date 10/22/24
Potential Completion Date 10/23/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,410.15 firm-fixed-price delivery order is for the supply of 4,565,879,521 units of Diclofenac Sodium Delayed-Release (EC) 25 mg tablets in 100-count bottles. The award has a completion date of September 20, 2024 and was made on September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,108.34 firm fixed-price delivery order is for the supply of DICLOFENAC POT 50 MG POWDR PKT 9S, a pharmaceutical product. The contract has a completion date of December 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,008.61 firm-fixed-price delivery order is for the supply of 4,565,214,273 units of Diclofenac Sodium Delayed-Release 75 mg Tablets in 1,000-count sizes. The contract has an ultimate completion date of July 23, 2024 and does not utilize a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.77 delivery order contract is for the supply of 4563416288 diclofenac sodium extended-release 100 mg tablets. This award is not designated as a set-aside contract. The contract is a firm fixed-price delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $1,493.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,568,201,898 units of Diclofenac Sodium Delayed-Release 75 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of diclofenac potassium 50 mg tablets (100 count) to the Defense Logistics Agency (DLA). The contract, valued at $1,016.48, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award has an ultimate completion date of April 30, 2024. This contract is a delivery order and is priced on a firm fixed-price basis. The contract does not have a set-aside designation, indicating it was competed openly....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.27, is for the delivery of 100 mg tablets of the drug diclofenac sodium extended-release. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of DICLOFENAC POT 50 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $1,075.24 and a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is for the delivery of DICLOFENAC SOD ER 100 MG TAB 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 30, 2024 with a ceiling value of $1,454.21. The contract is a Firm Fixed Price Delivery Order with a completion date of December 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH6LJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,205.34 firm-fixed-price delivery order is for 4,566,178,064 units of Diclofenac Potassium 50 mg tablets, to be delivered by October 23, 2024.

The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.

Generated 1/22/25, 12:58 AM